SEOM clinical guidelines for the treatment of diffuse large B-cell lymphoma
| Autor: | Mariano Provencio Pulla, José Gómez Codina, Antonio Rueda Domínguez, Dolores Isla Casado, Pilar Sabin Domínguez |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Cancer Research
medicine.medical_specialty Pathology medicine.medical_treatment Disease CHOP Medical Oncology immune system diseases Chemoimmunotherapy hemic and lymphatic diseases medicine Humans Societies Medical Chemotherapy business.industry General Medicine medicine.disease Comorbidity Lymphoma Oncology Spain Practice Guidelines as Topic Rituximab Lymphoma Large B-Cell Diffuse Radiology business Diffuse large B-cell lymphoma Algorithms medicine.drug |
| Zdroj: | CLINICAL & TRANSLATIONAL ONCOLOGY r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe instname |
| ISSN: | 1699-3055 1699-048X |
| Popis: | Diffuse large B-cell non-Hodgkin's lymphoma (LDCGB) is one of the best examples of chemotherapy curable malignant diseases. This "Oncoguía SEOM" summarizes the basic directions of staging and recommended treatment options. The staging study should be thorough and includes clinical, laboratory, diagnostic imaging and nuclear medicine. Treatment depends on patient characteristics and comorbidity and on disease extension and prognostic factors. In localized cases, chemoimmunotherapy (CHOP-R) of short duration, followed by involved-field irradiation is the preferred option. In advanced stages, the association of CHOP-like chemotherapy and Rituximab has been a major breakthrough in terms of cure rate. It is important do not forget the supportive treatment in these patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink